Hype Or Hope? Latest Research On GLP-1 Receptor Agonists And Addiction

forbes.com/sites/lipiroy/2025/05/06/hype-or-hope-latest-research-on-glp-1-receptor-agonists-and-addiction

Glucagon-like peptide (GLP-1) receptor agonists like semaglutide and liraglutide are already game-changers for obesity and type 2 diabetes. Could addiction be next?

This story appeared on forbes.com, 2025-05-06 12:49:12.
The Entire Business World on a Single Page. Free to Use →